TTK Healthcare Limited — Important, 27-06-2025: Updates

TTK Healthcare has announced a board meeting on July 25, 2025, to approve the financial results for the quarter and half-year ended March 31, 2025. The company reported a 6% revenue growth to Rs. 801.49 Cr with a profit before tax of Rs. 108.33 Cr, boosted by a Rs. 19.77 Cr land sale gain, partially offset by a Rs. 5.86 Cr write-off on male contraceptive inventory due to a USAID stop work order. Core businesses showed mixed growth: Consumer Products +5%, Animal Welfare +9%, Medical Devices +2%, Ortho +18%, Protective Devices +4%, Foods +7%. Cash and bank balances stand at over Rs. 87.5 Cr, with borrowings steady at Rs. 22 Cr. The company declared a dividend of Rs. 10/share. New Independent Directors joined, and the CEO was redesignated as Managing Director. Operations showed continued focus on brand building, new product launches, and market expansions, with digital initiatives driving growth in the Pleasure Products segment.